# Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study

> **NCT01647568** · — · COMPLETED · sponsor: **Dallas VA Medical Center** · enrollment: 715 (actual)

## Conditions studied

- Post-polypectomy Bleeding
- Anti-platelet Therapy
- Colonoscopy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01647568
- **Lead sponsor:** Dallas VA Medical Center
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 715 (ACTUAL)
- **Last updated:** 2012-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647568, "Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01647568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*